Yoshisato Shibata Selected Research

Drug-Eluting Stents

1/2023	Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy.
1/2022	CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.
1/2020	Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
1/2018	Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.
5/2016	The impact of three-dimensional optical coherence tomography and kissing-balloon inflation for stent implantation to bifurcation lesions.
1/2012	Presence of older thrombus in patients with late and very late drug-eluting stent thrombosis.
9/2010	Composition of thrombi in late drug-eluting stent thrombosis versus de novo acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshisato Shibata Research Topics

Disease

31	Myocardial Infarction 01/2024 - 11/2008
13	Thrombosis (Thrombus) 01/2024 - 07/2006
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2004
9	ST Elevation Myocardial Infarction 02/2024 - 04/2016
9	Hemorrhage 07/2023 - 01/2012
8	Heart Failure 10/2022 - 01/2004
7	Atrial Fibrillation 07/2023 - 10/2016
7	Stroke (Strokes) 07/2023 - 01/2018
6	Unstable Angina 01/2021 - 02/2003
5	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2017
4	Death (Near-Death Experience) 12/2023 - 05/2018
4	Stable Angina 01/2022 - 02/2003
4	Acute Coronary Syndrome 01/2022 - 01/2017
3	Atherosclerosis 01/2024 - 10/2021
3	Embolism (Embolus) 07/2023 - 01/2022
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2017
3	Type 2 Diabetes Mellitus (MODY) 11/2018 - 01/2017
2	Cardiogenic Shock 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2004
2	Myocarditis (Carditis) 01/2022 - 01/2021
2	No-Reflow Phenomenon 07/2021 - 12/2019
2	Atherosclerotic Plaque (Atheroma) 02/2021 - 01/2012
2	Frailty 01/2021 - 08/2020
2	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2019 - 01/2016
2	Infarction (Infarctions) 09/2018 - 04/2016
2	Ischemia 10/2016 - 11/2010
1	Hyperuricemia 01/2024
1	Disease Progression 01/2024
1	Coronary Restenosis 01/2024
1	Cerebral Infarction 07/2023
1	Aortic Dissection 07/2023
1	AIDS-Related Complex (ARC) 01/2023
1	Peripheral Arterial Disease 10/2021
1	Anemia 10/2021
1	Coronary Aneurysm (Aneurysm, Coronary) 08/2021
1	Rupture 02/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Chronic Renal Insufficiency 01/2021

Drug/Important Bio-Agent (IBA)

11	omega-Chloroacetophenone (Mace)IBA 12/2023 - 11/2010
5	LipidsIBA 02/2024 - 01/2012
5	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024 - 06/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 10/2016
3	Warfarin (Coumadin)FDA LinkGeneric 07/2023 - 01/2022
3	Serum AlbuminIBA 01/2022 - 08/2020
3	TroponinIBA 01/2021 - 06/2017
2	PTX3 proteinIBA 01/2024 - 01/2012
2	AnticoagulantsIBA 07/2023 - 10/2022
2	Everolimus FDA Link 01/2023 - 11/2019
2	Clopidogrel (Plavix)FDA Link 01/2022 - 10/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2020
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2021
2	C-Reactive ProteinIBA 01/2012 - 02/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2024
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024
1	Xanthine OxidaseIBA 01/2024
1	Febuxostat FDA Link 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2023
1	Bio-glueIBA 07/2023
1	CalciumIBA 01/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	AlbuminsIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	MetalsIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Streptokinase FDA Link 01/2022
1	Complement C1q (C1q Complement)IBA 01/2022
1	CholesterolIBA 10/2021
1	BilirubinIBA 02/2021
1	von Willebrand FactorIBA 02/2021
1	IronIBA 02/2021
1	FibrinIBA 02/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2020
1	Phosphotransferases (Kinase)IBA 08/2020

Therapy/Procedure

20	Percutaneous Coronary Intervention 01/2024 - 11/2008
13	Therapeutics 02/2024 - 04/2016
12	Stents 12/2023 - 01/2012
7	Drug-Eluting Stents 01/2023 - 09/2010
4	Secondary Prevention 10/2021 - 09/2018
3	Catheter Ablation 12/2022 - 10/2016
2	Cardiac Rehabilitation 10/2022 - 08/2020
2	Renal Dialysis (Hemodialysis) 01/2017 - 01/2004
1	Lasers (Laser) 04/2023
1	Electric Countershock (Cardioversion) 12/2022
1	Denervation 01/2022
1	Catheters 01/2022
1	Critical Care (Surgical Intensive Care) 01/2021
1	Activities of Daily Living (ADL) 01/2021